Donald Spicer, MD
Urology · Paducah, KYNPI 1588668867
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations.
Across 178 payments — averaging $22.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$642
- Axonics, Inc.$565
- Boston Scientific$420
- Astellas Pharma US Inc$372
- Procept Biorobotics Corporation$225
- Sumitomo Pharma America, Inc.$218
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,81796%
- Education$1704%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(3 entities) | 30 | $642 |
| Axonics, Inc. | 10 | $565 |
| Boston Scientific | 20 | $420 |
| Astellas Pharma US Inc | 24 | $372 |
| Procept Biorobotics Corporation | 6 | $225 |
| Sumitomo Pharma America, Inc. | 11 | $218 |
| Urogen Pharma, Inc. | 8 | $166 |
| Pfizer | 9 | $142 |
| Tolmar Pharmaceuticals, Inc. | 7 | $122 |
| Coloplast | 6 | $118 |
| Intuitive Surgical | 2 | $117 |
| C. R. Bard, Inc. & Subsidiaries | 5 | $114 |
| AbbVie | 5 | $108 |
| 180 Medical, Inc. | 4 | $108 |
| Teleflex LLC | 4 | $85 |
| Sun Pharmaceutical Industries Inc. | 3 | $67 |
| Urovant Sciences Inc | 3 | $44 |
| Zyla Life Sciences, Inc. | 3 | $35 |
| Medtronic(2 entities) | 2 | $34 |
| Photocure Inc | 2 | $33 |
| Laborie Medical Technologies Corp. | 2 | $32 |
| ABC Home Medical Supply, Inc. | 2 | $32 |
| Valencia Technologies Corporation | 1 | $27 |
| Baxter Healthcare | 1 | $24 |
| Olympus America Inc. | 1 | $21 |
| KARL Storz Endoscopy-america | 1 | $19 |
| Bayer | 1 | $18 |
| Progenics Pharmaceuticals, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Immunitybio, Inc. | 1 | $16 |
| Novartis | 1 | $14 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bulkamid$371
- Axonics$371
- AquaBeam Robotic System$111
How this compares
$3,987 in reported general payments places this provider in the 60th percentile of 139 urology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 69 | $47,850 |
| Tamsulosin Hcl | 330 | $3,813 |
| Finasteride | 193 | $2,505 |
| Silodosin | 13 | $1,185 |
| Tolterodine Tartrate ErTolterodine Tartrate | 12 | $1,047 |
| Dutasteride | 18 | $650 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 34 | $584 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 13 | $507 |
| Solifenacin Succinate | 15 | $494 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 143 | $340 |
| Cefdinir | 29 | $325 |
| Terazosin Hcl | 19 | $277 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $122 |
| Levofloxacin | 20 | $41 |
| Cephalexin | 34 | $38 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $372 | $47,85069 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 139 urology providers in Kentucky.
Other urology in Paducah
- Patrick EllisonPaducah$7K
- Michael KnoxPaducah$4K
- Thomas SlabaughLexington$102K
- Uzoma AneleLouisville$60K
- Lee EvansHopkinsville$56K
- Patrick HensleyLexington$50K
- Brooke EdwardsCrestview Hills$45K
- Robert LarkeCrestview Hills$22K
- Stephen MonnigLexington$18K
- Kellen ChoiLouisville$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.